This inventor holds 1 USPTO granted patent. Top assignee: University of Illinois. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Jesse Gordon-Blake: Innovator in Nicotinamide Adenine Dinucleotide Research
Introduction
Jesse Gordon-Blake is an accomplished inventor based in Chicago, IL (US). He has made significant contributions to the field of biochemistry, particularly in the development of compounds that enhance the levels of nicotinamide adenine dinucleotide (NAD) in subjects. His innovative work has the potential to address various neurodegenerative diseases.
Latest Patents
Jesse holds a patent for "Compounds for increasing the nicotinamide adenine dinucleotide in a subject and methods of use thereof." This patent outlines compounds that can elevate NAD levels, which may help in treating or preventing diseases associated with reduced NAD levels. By increasing NAD, symptoms of conditions such as Parkinson's disease, Alzheimer's disease, Huntington's disease, multiple sclerosis, amyotrophic lateral sclerosis, AIDS-induced dementia, and epilepsy can potentially be reduced or ameliorated.
Career Highlights
Jesse is affiliated with the University of Illinois, where he conducts research and develops innovative solutions in the field of health and medicine. His work is characterized by a commitment to improving the quality of life for individuals affected by debilitating diseases.
Collaborations
Jesse collaborates with talented individuals such as Kiira Ratia and Victoria Weidig, who contribute to his research efforts and help advance the understanding of NAD-related therapies.
Conclusion
Jesse Gordon-Blake's contributions to the field of biochemistry through his innovative patent on NAD-boosting compounds highlight the importance of research in combating neurodegenerative diseases. His work at the University of Illinois exemplifies the potential of scientific innovation to improve health outcomes.